Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Site-specific in situ generation of allicin using a targeted alliinase delivery system for the treatment of cancers, tumors, infectious diseases and other allicin-sensitive diseases

Site-specific in situ generation of allicin using a targeted alliinase delivery system for the treatment of cancers, tumors, infectious diseases and other allicin-sensitive diseases

US Patent 7445802 · Granted Nov 4, 2008

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Composition comprising S-allylmercapto-N-acetylcysteine (ASSNAC) for up-regulati2013
Composition comprising S-allylmercapto-N-acetylcysteine (ASSNAC) for up-regulati2013
Allylmercaptocaptopril compounds and uses thereof2007
Allylmercaptocaptopril compounds and uses thereof2007
Allylmercaptocaptopril compounds and uses thereof2007
Allylmercaptocaptopril compounds and uses thereof2007
Avidin derivatives and uses thereof2007
Garlic alliinase covalently bound to carrier for continuous production of allici2004
Garlic alliinase covalently bound to carrier for continuous production of allici2004
Garlic alliinase covalently bound to carrier for continuous production of allici2004
Garlic alliinase covalently bound to carrier for continuous production of allici2004
Modified avidin-type molecules as targeting agents for the liver and cells of th2003